Genetic Technologies Announced Earlier Upcoming Launch Of World’s First Comprehensive Risk Test For Breast & Ovarian Cancer
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce the Company will launch a ‘World First' Comprehensive Risk Assessment Test which evaluates a women's risk of developing Breast and/or Ovarian Cancer either from a hereditary genetic mutation or from the far more common familial or sporadic cancer.